
Money raised through U.S. neurology company IPOs 2006-2021
During 2021, as of third quarter, neurology companies in the U.S. raised nearly 700 million U.S. dollars by going public. This statistic shows the amount of money which R&D stage emerging neurology companies in the U.S. raised through initial public offerings from 2006 to 2021.